JP7678994B2 - 架橋型ヌクレオシドおよびそれを用いたヌクレオチド - Google Patents
架橋型ヌクレオシドおよびそれを用いたヌクレオチド Download PDFInfo
- Publication number
- JP7678994B2 JP7678994B2 JP2022501990A JP2022501990A JP7678994B2 JP 7678994 B2 JP7678994 B2 JP 7678994B2 JP 2022501990 A JP2022501990 A JP 2022501990A JP 2022501990 A JP2022501990 A JP 2022501990A JP 7678994 B2 JP7678994 B2 JP 7678994B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- amino
- nucleic acid
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020026646 | 2020-02-19 | ||
| JP2020026646 | 2020-02-19 | ||
| PCT/JP2021/006222 WO2021167029A1 (ja) | 2020-02-19 | 2021-02-18 | 架橋型ヌクレオシドおよびそれを用いたヌクレオチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021167029A1 JPWO2021167029A1 (https=) | 2021-08-26 |
| JP7678994B2 true JP7678994B2 (ja) | 2025-05-19 |
Family
ID=77391326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501990A Active JP7678994B2 (ja) | 2020-02-19 | 2021-02-18 | 架橋型ヌクレオシドおよびそれを用いたヌクレオチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12606589B2 (https=) |
| EP (1) | EP4108670A4 (https=) |
| JP (1) | JP7678994B2 (https=) |
| CN (1) | CN115151555B (https=) |
| WO (1) | WO2021167029A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250179109A1 (en) * | 2022-03-01 | 2025-06-05 | Osaka University | 5'-modified nucleoside and nucleotide using same |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009006478A2 (en) | 2007-07-05 | 2009-01-08 | Isis Pharmaceuticals, Inc. | 6-disubstituted bicyclic nucleic acid analogs |
| WO2015125783A1 (ja) | 2014-02-18 | 2015-08-27 | 国立大学法人大阪大学 | 架橋型ヌクレオシドおよびヌクレオチド |
| WO2017119463A1 (ja) | 2016-01-07 | 2017-07-13 | 国立大学法人大阪大学 | α-シヌクレイン発現抑制剤 |
| WO2018155451A1 (ja) | 2017-02-21 | 2018-08-30 | 国立大学法人大阪大学 | 核酸化合物およびオリゴヌクレオチド |
| WO2019009298A1 (ja) | 2017-07-05 | 2019-01-10 | 国立大学法人大阪大学 | α-シヌクレイン発現抑制剤 |
| WO2020027227A1 (ja) | 2018-07-31 | 2020-02-06 | 国立大学法人大阪大学 | オリゴヌクレオチドを含有する小細胞肺癌治療薬 |
-
2021
- 2021-02-18 EP EP21756952.4A patent/EP4108670A4/en active Pending
- 2021-02-18 WO PCT/JP2021/006222 patent/WO2021167029A1/ja not_active Ceased
- 2021-02-18 US US17/791,799 patent/US12606589B2/en active Active
- 2021-02-18 CN CN202180015710.XA patent/CN115151555B/zh active Active
- 2021-02-18 JP JP2022501990A patent/JP7678994B2/ja active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009006478A2 (en) | 2007-07-05 | 2009-01-08 | Isis Pharmaceuticals, Inc. | 6-disubstituted bicyclic nucleic acid analogs |
| WO2015125783A1 (ja) | 2014-02-18 | 2015-08-27 | 国立大学法人大阪大学 | 架橋型ヌクレオシドおよびヌクレオチド |
| WO2017119463A1 (ja) | 2016-01-07 | 2017-07-13 | 国立大学法人大阪大学 | α-シヌクレイン発現抑制剤 |
| WO2018155451A1 (ja) | 2017-02-21 | 2018-08-30 | 国立大学法人大阪大学 | 核酸化合物およびオリゴヌクレオチド |
| WO2019009298A1 (ja) | 2017-07-05 | 2019-01-10 | 国立大学法人大阪大学 | α-シヌクレイン発現抑制剤 |
| WO2020027227A1 (ja) | 2018-07-31 | 2020-02-06 | 国立大学法人大阪大学 | オリゴヌクレオチドを含有する小細胞肺癌治療薬 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115151555B (zh) | 2026-03-17 |
| CN115151555A (zh) | 2022-10-04 |
| EP4108670A4 (en) | 2024-04-17 |
| EP4108670A1 (en) | 2022-12-28 |
| WO2021167029A1 (ja) | 2021-08-26 |
| JPWO2021167029A1 (https=) | 2021-08-26 |
| US12606589B2 (en) | 2026-04-21 |
| US20230340008A1 (en) | 2023-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5030998B2 (ja) | ヌクレオシド類縁体およびそのヌクレオチド類縁体を含むオリゴヌクレオチド誘導体 | |
| EP2495248B1 (en) | Bridged artificial nucleoside and nucleotide | |
| EP3109254B1 (en) | Crosslinked nucleoside and nucleotide | |
| JP4731324B2 (ja) | N−o結合性架橋構造型新規人工核酸 | |
| JP4151751B2 (ja) | 新規ビシクロヌクレオシド類縁体 | |
| JP6562517B2 (ja) | 架橋型ヌクレオシドおよびヌクレオチド | |
| JP7441523B2 (ja) | 5’位修飾ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP7438546B2 (ja) | 5’位修飾ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP7678994B2 (ja) | 架橋型ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP7650412B2 (ja) | 5′位修飾ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP7709690B2 (ja) | 架橋型ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP2023110119A (ja) | 5’位修飾ヌクレオシドおよびそれを用いたヌクレオチド | |
| JP4255227B2 (ja) | N3’−p5’結合を有する2’,4’−bnaオリゴヌクレオチド | |
| CN118946575A (zh) | 5'位修饰核苷和使用其的核苷酸 | |
| JPWO2003068794A1 (ja) | 核酸糖部をs型に束縛したヌクレオシド類縁体およびそのヌクレオチド類縁体を含むオリゴヌクレオチド誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220705 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250204 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250325 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250408 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250418 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7678994 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |